Showing 691-700 of 6902 results for "".
Alloimmune Neutropenia of the Fetus and Newborn
https://reachmd.com/programs/cme/alloimmune-neutropenia-of-the-fetus-and-newborn/13910/NAIN is rare and potentially life-threatening. What clues can increase your awareness and help you modify the clinical course of this disease?Harnessing the NAFLD/NASH Epidemic: Preparing for a New Treatment Paradigm
https://reachmd.com/programs/cme/harnessing-the-nafldnash-epidemic-preparing-for-a-new-treatment-paradigm/15673/Do you understand your role in determining which patient may benefit the most from NASH therapy?Alloimmune Thrombocytopenia in the Fetus and Newborn
https://reachmd.com/programs/cme/alloimmune-thrombocytopenia-in-the-fetus-and-newborn/13909/In severe cases, FNAIT can lead to fetal intracranial hemorrhage. How can you lower risks for your patients facing this uncommon disorder?A Clinician’s Action Guide for Psoriasis Awareness Month
https://reachmd.com/programs/dermconsult/a-clinicians-action-guide-for-psoriasis-awareness-month/24125/Here’s how you can support patients, educate the public, and become a patient advocate during Psoriasis Awareness Month and beyond.Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
https://reachmd.com/programs/cme/special-report-management-considerations-and-unmet-needs-in-lgs-and-dravet-syndrome/15112/Find out how you can manage polypharmacy in Lennox-Gastaut syndrome and Dravet syndrome and learn what new therapies are on the horizon.Incorporating Targeted Therapies in Treatment Planning for AAV
https://reachmd.com/programs/cme/incorporating-targeted-therapies-in-treatment-planning-for-aav/14962/Our experts offer tips to effectively manage your patients with AAV & improve their quality of life by incorporating C5a receptor antagonist therapy.Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
https://reachmd.com/programs/cme/red-blood-cell-alloimmunization-pathophysiology-diagnosis-treatment-and-prevention/13907/HDFN is rare, under recognized, and undermanaged. Are you doing everything you can to mitigate potentially devastating outcomes for your patients?Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
https://reachmd.com/programs/cme/parallels-between-kidney-transplantation-and-maternal-anti-fetal-rejection/13911/Get below the surface and explore what kidney transplantation & maternal anti-fetal rejection have in common. The answer could change your practice.How AI Is Changing Digital Marketing
https://reachmd.com/ma-issues-index/july-august-2025/artificial-intelligence-changing-digital-marketing/36662/Will artificial intelligence (AI) replace your aesthetic practice’s marketing strategy or improve it? That’s the question many aesthetic clinicians and med spa owners are asking. The question isn’t so much whether AI will affect digital marketing, but how heavily it will reshape patient discovery, sStopping aspirin after 1 month DAPT in ACS patients after stenting
https://reachmd.com/programs/acc-action-center/stopping-aspirin-after-1-month-dapt-in-acs-patients-after-stenting/24290/ACC.24 - Study results from the ULTIMATE-DAPT show that aspirin can be stopped in ACS patients who underwent PCI and tolerated 1 month of DAPT -ticagrelor and aspirin- well. "You will be doing a favor for your patients," said Gregg Stone.